FIELD: medicine, hematology, pharmacy. SUBSTANCE: method involves the use of dexamethasone as an agent stimulating granulocyte hemopoiesis graft in cytostatic myelodepression. Invention can be used in pharmacological correction of blood system disorders in cytostatic myelo-depression. EFFECT: high effectiveness of agent, decreased adverse effect. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
| MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
| AGENT STIMULATING ERYTHROIDAL AND GRANULOCYTIC HEMOPOIESIS STEMS IN CYTOSTATIC MYELODEPRESSION | 2003 |
|
RU2243782C1 |
| MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
| METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
| ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
| METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
| METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
| METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
| METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
Authors
Dates
2000-10-20—Published
1999-09-28—Filed